Harrow Health Inc.

NASDAQ: HROW · Real-Time Price · USD
38.66
-1.35 (-3.37%)
At close: Aug 15, 2025, 12:18 PM

Harrow Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
63.74M 47.83M 66.83M 49.26M 48.94M 34.59M 36.35M 34.27M 33.47M 26.1M 20.33M 22.82M 23.32M 22.12M 20.19M 18.71M 18.13M 15.44M
Cost of Revenue
16.23M 15.52M 14.13M 12.02M 12.54M 10.55M 11.3M 10.07M 10M 8.27M 6.17M 6.72M 6.53M 5.96M 5.08M 4.95M 4.42M 3.77M
Gross Profit
47.51M 32.31M 52.7M 37.24M 36.4M 24.03M 25.05M 24.2M 23.47M 17.83M 14.16M 16.1M 16.79M 16.16M 15.11M 13.76M 13.72M 11.67M
Operating Income
11.41M -11.23M 12.9M 1.32M 1.53M -6.93M -4.88M 1.74M 2.35M 1.21M -1.78M -94K 1.69M 2.1M -1.75M -3.72M 4.17M 2.92M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.86M n/a n/a n/a n/a n/a n/a n/a
Pretax Income
5M -17.78M 6.26M -4.2M -5.82M -13.56M -9.68M -2.85M -4.24M -6.93M 1.05M -6.43M -6.2M -2.44M -7.29M -8.33M -2.48M 217K
Net Income
5M -17.78M 6.78M -4.22M -6.47M -13.56M -9.15M -4.39M -4.23M -6.64M 1.05M -6.46M -6.24M -2.44M -7.42M -8.33M -2.48M 217K
Selling & General & Admin
33.23M 40.51M 34.79M 33.65M 31.82M 28.81M 26.21M 21.03M 19.96M 15.89M 15.24M 15.42M 14.19M 13.4M 12.67M 11.36M 9.12M 8.16M
Research & Development
2.87M 3.03M 4.75M 2.27M 3.05M 2.15M 3.34M 1.42M 1.16M 734K 703K 775K 914K 658K 3.94M 6.13M 425K 592K
Other Expenses
n/a n/a 253K n/a n/a n/a 380K n/a n/a n/a n/a n/a n/a n/a 249K n/a -51K n/a
Operating Expenses
36.1M 43.54M 39.8M 35.92M 34.87M 30.96M 29.93M 22.45M 21.12M 16.62M 15.94M 16.2M 15.1M 14.06M 16.61M 17.48M 9.55M 8.76M
Interest Expense
6.41M 6.55M 6.38M 5.53M 5.47M 5.42M 5.12M 5.75M 5.7M 4.75M 5.44M 1.8M 1.79M 1.79M 1.92M 1.69M 1.31M 513K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
52.33M 59.06M 53.93M 47.94M 47.41M 41.52M 41.23M 32.52M 31.12M 24.89M 22.11M 22.92M 21.63M 20.02M 21.94M 22.43M 13.96M 12.53M
Income Tax Expense
n/a n/a -514K 20K 655K n/a -535K 1.54M -15K -288K n/a 35K 40K n/a 133K n/a n/a n/a
Shares Outstanding (Basic)
36.79M 35.83M 35.81M 35.7M 35.62M 35.47M 35.35M 34.26M 30.46M 30.29M 27.96M 27.35M 27.3M 27.09M 27.47M 27.11M 26.74M 26.02M
Shares Outstanding (Diluted)
38.85M 35.83M 35.81M 35.7M 35.62M 35.47M 35.35M 34.26M 30.46M 30.29M 29.43M 27.35M 27.3M 27.23M 27.47M 27.11M 26.74M 27.48M
EPS (Basic)
0.14 -0.5 0.19 -0.12 -0.18 -0.38 -0.26 -0.13 -0.14 -0.22 0.04 -0.24 -0.23 -0.09 -0.27 -0.31 -0.11 0.01
EPS (Diluted)
0.13 -0.5 0.19 -0.12 -0.18 -0.38 -0.26 -0.13 -0.14 -0.22 0.04 -0.24 -0.23 -0.09 -0.27 -0.31 -0.11 0.01
EBITDA
16.31M -6.32M 17.45M 4.67M 2.85M -4.97M -1.68M 6.07M 4.88M 492K 3.85M -3.81M -3.44M 301K 9.52M -6.08M -562K 1.38M
EBIT
11.4M -11.23M 12.64M 1.32M -347K -8.15M -4.56M 2.9M 1.46M -2.18M 2.91M -4.63M -4.41M -646K 8.94M -6.64M -1.16M 730K
Depreciation & Amortization
4.9M 4.91M 4.81M 3.35M 3.2M 3.18M 2.88M 3.17M 3.42M 2.68M 940K 817K 961K 780K 481K 565K 602K 652K